Storm Beadle has joined Cognite, the international Strategy and Communications agency based in London and Zurich. Storm, who joins as a Senior Account Manager, left university with a degree focused on ...
The former president of AstraZeneca UK and the ABPI has given up big pharma to join biotech Redx. We speak to her about what prompted the change, how she thinks British life science will fare in the ...
The NHS is set to save a record £300 million after negotiating deals with five manufacturers on low-cost versions of the health service’s most costly drug. The NHS is set to save a record £300 million ...
The monoclonal antibody combination is being tested for prevention and treatment of coronavirus AstraZeneca has dosed the first participants in a Phase I trial of AZD7442, a combination of two ...
Silence Therapeutics has appointed Dr David Horn Solomon as its new CEO. David is an experienced public company biotech CEO, board member and biotech investor. He was the CEO of Zealand Pharma from ...
Ahead of a review tomorrow, agency staff at the US regulator are recommending that labelling for Roche’s Tamiflu and GlaxoSmithKline’s Relenza should include an update of precautions about ...
Allergan has reported mixed top-line data from a mid-stage trial testing Botox as a treatment for major depressive disorder (MDD), but says the results are “encouraging” and warrant a move into Phase ...
Theragnostics will lead the development of the tracer, GalliProst, while GE Healthcare will lead all pre-approval commercial preparations. GE Healthcare and Theragnostics have announced the forming of ...
The UK has launched a five-year action plan and 20-year vision for antimicrobial resistance (AMR). The UK has launched a five-year action plan and 20-year vision for antimicrobial resistance (AMR), ...
How an industry-funded review of primary care atrial fibrillation patients has saved the NHS over £82 million Atrial fibrillation is putting a huge burden on the NHS. The condition, which causes an ...
Local councils are calling for “urgent action” on obesity on the back of data showing that more than 600 children and teenagers are now being treated for type II diabetes, which is largely preventable ...
US regulators have further expanded the scope of AstraZeneca and MSD’s Lynparza to include treatment of patients with BCRA-mutant metastatic breast cancer. US regulators have further expanded the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback